FERRARI, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.980
EU - Europa 1.095
AS - Asia 406
SA - Sud America 2
AF - Africa 1
Totale 3.484
Nazione #
US - Stati Uniti d'America 1.974
IE - Irlanda 261
PL - Polonia 252
IT - Italia 224
SE - Svezia 170
HK - Hong Kong 166
CN - Cina 95
RU - Federazione Russa 67
SG - Singapore 51
DE - Germania 49
JO - Giordania 47
IN - India 23
GB - Regno Unito 22
KR - Corea 11
UA - Ucraina 9
FI - Finlandia 8
VN - Vietnam 8
BE - Belgio 7
CH - Svizzera 7
ES - Italia 5
CA - Canada 4
CZ - Repubblica Ceca 3
JP - Giappone 3
BR - Brasile 2
DK - Danimarca 2
FR - Francia 2
NL - Olanda 2
BG - Bulgaria 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
TR - Turchia 1
Totale 3.484
Città #
Ashburn 409
Dublin 260
Warsaw 252
Fairfield 228
Chandler 217
Woodbridge 122
Hong Kong 108
Seattle 97
Houston 94
Cambridge 85
Altamura 79
Lawrence 77
Wilmington 66
Ann Arbor 58
Moscow 46
Florence 45
Princeton 45
Dearborn 43
Boston 35
Buffalo 34
Bremen 33
Singapore 30
Shanghai 27
San Diego 24
New York 23
Pune 21
Beijing 18
Medford 18
Kent 16
Rome 13
Boardman 12
West Jordan 12
Seoul 11
Ferrara 8
Brussels 7
Dong Ket 6
Falls Church 6
Lambeth 6
Norwalk 6
Barcelona 5
Misano Adriatico 5
Prato 5
Genoa 4
Hefei 4
Hillsboro 4
Milan 4
Toronto 4
Wenzhou 4
Zhengzhou 4
Zurich 4
Bern 3
Fiesole 3
Guangzhou 3
London 3
Prague 3
Santa Maria A Monte 3
Siena 3
Turin 3
Afragola 2
Arezzo 2
Bolzano 2
Campi Bisenzio 2
Catania 2
Chicago 2
Codogno 2
Copenhagen 2
Council Bluffs 2
Dallas 2
Helsinki 2
Jenera 2
Jinan 2
Kilburn 2
Kunming 2
Lappeenranta 2
Los Angeles 2
Menlo Park 2
Monza 2
Nanchang 2
Nanjing 2
Pedrengo 2
Phoenix 2
Redwood City 2
Sant'Agata di Militello 2
Wuhan 2
Acton 1
Athens 1
Atlanta 1
Bitola 1
Bologna 1
Bristol 1
Budapest 1
Changsha 1
Chengdu 1
Chennai 1
Empoli 1
Fasano 1
Fontebuona 1
Harbin 1
Hounslow 1
Izmir 1
Totale 2.836
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 270
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 219
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 197
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 116
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 99
Biomarkers study in atypical dementia: proof of a diagnostic work-up 95
Primary Progressive Aphasia: Natural History in an Italian Cohort 94
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 88
The diagnosis of dementias: a practical tool not to miss rare causes 87
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 87
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 86
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 81
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 78
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 77
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 72
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 70
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 68
The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family 65
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 60
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 57
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 56
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 54
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 54
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 53
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 51
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 45
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 45
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 45
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 43
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 42
How can elderly apolipoprotein E ε4 carriers remain free from dementia? 38
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 38
The complexity of Alzheimer's disease: an evolving puzzle 36
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 36
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 36
Differential early subcortical involvement in genetic FTD within the GENFI cohort 36
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 35
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 34
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 34
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 33
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 33
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 32
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 31
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 31
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 30
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 30
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 29
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 28
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 28
Cognitive functioning among patients with diabetic foot 27
Intermediate alleles of HTT: A new pathway in longevity 26
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 24
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 24
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 23
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 23
Late-onset Huntington disease: An Italian cohort 22
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 21
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 20
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 18
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 17
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 15
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 15
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 14
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 13
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 11
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 11
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 9
Parkinson-ALS with a novel MAPT variant 8
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 8
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 7
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 6
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 5
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 5
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 4
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 4
Totale 3.562
Categoria #
all - tutte 17.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020542 24 32 10 28 77 77 90 68 60 28 38 10
2020/2021357 27 36 19 46 13 14 13 22 50 73 17 27
2021/2022311 6 7 17 12 4 24 1 40 13 20 66 101
2022/20231.135 101 229 73 89 65 199 155 56 125 6 23 14
2023/2024899 30 50 73 32 39 84 57 402 23 52 37 20
2024/202561 61 0 0 0 0 0 0 0 0 0 0 0
Totale 3.562